CRCP
BIO icon

Copper Rock Capital Partners’s Bio-Rad Laboratories Class A BIO Stock Holding History

Copper Rock Capital Partners’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-176,793
Closed -$24.5M – 57
2015
Q4 		$24.5M Sell
176,793
-643
-0.4% -$89.1K 2.04% 21
2015
Q3 		$23.8M Sell
177,436
-865
-0.5% -$124K 2.01% 24
2015
Q2 		$26.9M Buy
178,301
+23,376
+15% +$3.34M 1.99% 28
2015
Q1 		$20.9M Buy
154,925
+16,748
+12% +$2.08M 1.72% 34
2014
Q4 		$16.7M Buy
138,177
+9,360
+7% +$1.08M 1.55% 41
2014
Q3 		$14.6M Buy
128,817
+38,663
+43% +$4.58M 1.59% 39
2014
Q2 		$10.8M Buy
90,154
+3,187
+4% +$389K 1.72% 37
2014
Q1 		$11.1M Buy
86,967
+3,470
+4% +$445K 1.09% 32
2013
Q4 		$10.3M Buy
83,497
+1,815
+2% +$221K 1.01% 38
2013
Q3 		$9.6M Sell
81,682
-1,974
-2% -$233K 1.03% 36
2013
Q2 		$9.39M Buy
+83,656
New +$9.81M 1.01% 34

Other funds holding BIO

ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return

Copper Rock Capital Partners's BIO Position: Q1 2016 in Review

Copper Rock Capital Partners sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2016, closing a stake of 176,793 shares — an estimated $24.5M sold.

Copper Rock Capital Partners first reported a position in BIO in Q2 2013 and held it in 11 quarters. The position peaked at $26.9M in Q2 2015. 232 funds tracked by Wall St. Rank hold BIO as of Q1 2016.

  • Copper Rock Capital Partners reported no remaining Bio-Rad Laboratories Class A position as of Q1 2016 after selling out during the quarter.
  • Copper Rock Capital Partners sold 176,793 Bio-Rad Laboratories Class A shares in Q1 2016, an estimated $24.5M.
  • Copper Rock Capital Partners first reported a position in Bio-Rad Laboratories Class A in Q2 2013 and held it in 11 quarters.
  • Copper Rock Capital Partners's Bio-Rad Laboratories Class A position peaked at $26.9M in Q2 2015.
  • 232 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2016.

Based on Copper Rock Capital Partners's 13F filing for Q1 2016, filed 5 Apr 2016.